112 related articles for article (PubMed ID: 26912430)
1. PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in the Brains of MPTP-Treated Monkeys.
Tsukada H; Kanazawa M; Ohba H; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2016 Jun; 57(6):950-3. PubMed ID: 26912430
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
Kanazawa M; Ohba H; Harada N; Kakiuchi T; Muramatsu S; Tsukada H
J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
[TBL] [Abstract][Full Text] [Related]
3. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
[TBL] [Abstract][Full Text] [Related]
4. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain.
Tsukada H; Nishiyama S; Fukumoto D; Kanazawa M; Harada N
J Nucl Med; 2014 Mar; 55(3):473-80. PubMed ID: 24470629
[TBL] [Abstract][Full Text] [Related]
5. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.
Harada N; Nishiyama S; Kanazawa M; Tsukada H
J Labelled Comp Radiopharm; 2013 Sep; 56(11):553-61. PubMed ID: 24285187
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 18F-BCPP-EF for mitochondrial complex 1 imaging in the brain of conscious monkeys using PET.
Tsukada H; Ohba H; Kanazawa M; Kakiuchi T; Harada N
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):755-63. PubMed ID: 24258008
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain.
Tsukada H; Ohba H; Nishiyama S; Kanazawa M; Kakiuchi T; Harada N
J Cereb Blood Flow Metab; 2014 Apr; 34(4):708-14. PubMed ID: 24447952
[TBL] [Abstract][Full Text] [Related]
8. The use of ¹⁸F-BCPP-EF as a PET probe for complex I activity in the brain.
Tsukada H
Methods Enzymol; 2014; 547():417-31. PubMed ID: 25416368
[TBL] [Abstract][Full Text] [Related]
9. Imaging mitochondrial complex I activation during a vibrotactile stimulation: A PET study using [
Fang J; Ohba H; Hashimoto F; Tsukada H; Chen F; Liu H
J Cereb Blood Flow Metab; 2020 Dec; 40(12):2521-2532. PubMed ID: 31948325
[TBL] [Abstract][Full Text] [Related]
10. Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma.
Murayama C; Kawaguchi AT; Kamijo A; Naito K; Kanazawa M; Tsukada H
PLoS One; 2017; 12(1):e0170911. PubMed ID: 28125711
[TBL] [Abstract][Full Text] [Related]
11. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys.
Tsukada H; Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Harada N
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2127-36. PubMed ID: 24919653
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 6-[(11)C]methyl-m-tyrosine ([(11)C]6MemTyr) for dopamine synthesis imaging in living brain using PET.
Kanazawa M; Ohba H; Iwazaki A; Kakiuchi T; Tsukada H
Bioorg Med Chem; 2015 Feb; 23(4):729-34. PubMed ID: 25596169
[TBL] [Abstract][Full Text] [Related]
13. Comparing α7 nicotinic acetylcholine receptor binding, amyloid-β deposition, and mitochondria complex-I function in living brain: A PET study in aged monkeys.
Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Tsukada H
Synapse; 2015 Oct; 69(10):475-83. PubMed ID: 26234533
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive evaluation of neuroprotective drug candidates for cerebral infarction by PET imaging of mitochondrial complex-I activity.
Fukuta T; Asai T; Ishii T; Koide H; Kiyokawa C; Hashimoto M; Kikuchi T; Shimizu K; Harada N; Tsukada H; Oku N
Sci Rep; 2016 Jul; 6():30127. PubMed ID: 27440054
[TBL] [Abstract][Full Text] [Related]
15. Automated Synthesis of
Kaur T; Brooks AF; Liddell KM; Henderson BD; Hockley BG; Bohnen NI; Albin RL; Scott PJH
Front Chem; 2022; 10():878835. PubMed ID: 35433631
[TBL] [Abstract][Full Text] [Related]
16. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study.
Doudet DJ; Rosa-Neto P; Munk OL; Ruth TJ; Jivan S; Cumming P
Neuroimage; 2006 Mar; 30(1):26-35. PubMed ID: 16378735
[TBL] [Abstract][Full Text] [Related]
17. Test-retest variability and reference region-based quantification of
Mansur A; Rabiner EA; Tsukada H; Comley RA; Lewis Y; Huiban M; Passchier J; Gunn RN
J Cereb Blood Flow Metab; 2021 Apr; 41(4):771-779. PubMed ID: 32501157
[TBL] [Abstract][Full Text] [Related]
18. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T
Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337
[TBL] [Abstract][Full Text] [Related]
19. Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
Morin N; Morissette M; Grégoire L; Di Paolo T
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():27-38. PubMed ID: 25046277
[TBL] [Abstract][Full Text] [Related]
20. Differences in in vitro microglial accumulation of the energy metabolism tracers [
Suzuki C; Han S; Kesavamoorthy G; Kosugi M; Araki K; Harada N; Kanazawa M; Tsukada H; Magata Y; Ouchi Y
Sci Rep; 2021 Jun; 11(1):13200. PubMed ID: 34168190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
